Cytokine production in bipolar affective disorder patients under lithium treatment
- 1 October 2004
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 82 (2) , 309-313
- https://doi.org/10.1016/j.jad.2004.01.007
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Anti-bipolar therapy: mechanism of action of lithiumMolecular Psychiatry, 1999
- Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical featuresMolecular Psychiatry, 1999
- Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCRJournal of Immunological Methods, 1997
- Depression and immunity: The biochemical interrelationship between the central nervous system and the immune systemBiological Psychiatry, 1995
- Effects of chronic lithium treatment on protein kinase c and cyclic AMP-dependent protein phosphorylationBiological Psychiatry, 1991
- A possible antiviral action of lithium carbonate in herpes simplex virus infectionsBiological Psychiatry, 1990
- Immune function in maniaBiological Psychiatry, 1988
- Lithium modulation of second messenger signal amplification in man: Inhibition of phosphatidylinositol- specific phospholipase C and adenylate cyclase activityPsychiatry Research, 1988
- Further studies on the ELISA-spot techniqueJournal of Immunological Methods, 1986
- Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substancesJournal of Immunological Methods, 1984